Haroon Ahmad

696 total citations
20 papers, 430 citations indexed

About

Haroon Ahmad is a scholar working on Genetics, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haroon Ahmad has authored 20 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haroon Ahmad's work include Glioma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (2 papers) and Meningioma and schwannoma management (2 papers). Haroon Ahmad is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (2 papers) and Meningioma and schwannoma management (2 papers). Haroon Ahmad collaborates with scholars based in United States, United Kingdom and Canada. Haroon Ahmad's co-authors include Collin T. Inglut, Shruti Vig, Huang‐Chiao Huang, Aaron J. Sorrin, David Schiff, Benjamin Purow, Camilo E. Fadul, Carl Shanholtz, Natalie Gahres and Søren M. Bentzen and has published in prestigious journals such as Stroke, Neuro-Oncology and Nanomaterials.

In The Last Decade

Haroon Ahmad

17 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haroon Ahmad United States 8 154 102 101 85 47 20 430
Ivan Seah Singapore 11 200 1.3× 33 0.3× 148 1.5× 61 0.7× 40 0.9× 20 966
Matteo Monieri Italy 10 176 1.1× 135 1.3× 80 0.8× 102 1.2× 12 0.3× 15 432
Qiyu Tang China 13 246 1.6× 123 1.2× 117 1.2× 103 1.2× 16 0.3× 44 644
Ece Tavukçuoğlu Türkiye 16 169 1.1× 124 1.2× 161 1.6× 80 0.9× 45 1.0× 26 505
Diğdem Yöyen-Ermiş Türkiye 12 123 0.8× 110 1.1× 118 1.2× 52 0.6× 60 1.3× 23 417
Joseph Piscitelli United States 9 126 0.8× 95 0.9× 113 1.1× 55 0.6× 38 0.8× 19 365
Daniel P. Feldmann United States 8 224 1.5× 45 0.4× 81 0.8× 48 0.6× 24 0.5× 10 418
Ilnaz Rahimmanesh Iran 14 285 1.9× 66 0.6× 59 0.6× 89 1.0× 13 0.3× 44 534
Huangliang Zheng China 12 119 0.8× 82 0.8× 46 0.5× 128 1.5× 63 1.3× 17 411

Countries citing papers authored by Haroon Ahmad

Since Specialization
Citations

This map shows the geographic impact of Haroon Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haroon Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haroon Ahmad more than expected).

Fields of papers citing papers by Haroon Ahmad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haroon Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haroon Ahmad. The network helps show where Haroon Ahmad may publish in the future.

Co-authorship network of co-authors of Haroon Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Haroon Ahmad. A scholar is included among the top collaborators of Haroon Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haroon Ahmad. Haroon Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Haroon, et al.. (2025). Safety and efficacy of novel potassium binders for chronic hyperkalemia: a systematic review and meta-analysis of randomized controlled trials. Baylor University Medical Center Proceedings. 39(1). 110–118.
2.
Saeed, Ali, et al.. (2024). Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients. Radiation Oncology. 19(1). 36–36. 1 indexed citations
3.
Luetkens, Tim, Rima Koka, Michael E. Kallen, et al.. (2024). Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells. Cancer Immunology Immunotherapy. 73(3). 45–45. 5 indexed citations
4.
Donahue, Joseph, Haroon Ahmad, Kester A. Phillips, et al.. (2022). The landscape of brain tumor mimics in neuro-oncology practice. Journal of Neuro-Oncology. 159(3). 499–508. 6 indexed citations
5.
Ferris, Margaret, et al.. (2021). Secondary Hemophagocytic Lymphohistiocytosis Causing Hemorrhagic Encephalomyelitis and Spinal Subarachnoid Hemorrhage: A Case Report. The Neurohospitalist. 12(2). 332–336. 1 indexed citations
6.
Holtzman, Noa G., Hao Xie, Søren M. Bentzen, et al.. (2020). Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes. Neuro-Oncology. 23(1). 112–121. 71 indexed citations
7.
Inglut, Collin T., et al.. (2020). Immunological and Toxicological Considerations for the Design of Liposomes. Nanomaterials. 10(2). 190–190. 255 indexed citations
8.
9.
Ahmad, Haroon, David Martin, Sohil H. Patel, et al.. (2019). Oligodendroglioma confers higher risk of radiation necrosis. Journal of Neuro-Oncology. 145(2). 309–319. 7 indexed citations
10.
Ahmad, Haroon & David Schiff. (2019). Multimodality Therapy of Patients with Refractory Meningiomas. Current Treatment Options in Oncology. 20(6). 50–50. 3 indexed citations
11.
Ahmad, Haroon, Camilo E. Fadul, David Schiff, & Benjamin Purow. (2019). Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomas. Neuro-Oncology Practice. 6(6). 424–427. 22 indexed citations
12.
Ahmad, Haroon, et al.. (2018). Should medical entrepreneurship be included in the undergraduate curriculum? A literature review. British Journal of Healthcare Management. 24(1). 40–44. 2 indexed citations
13.
Persaud, Navindra & Haroon Ahmad. (2017). Canadian list of essential medications: Potential and uncertainties.. PubMed. 63(4). 266–268. 6 indexed citations
14.
Ahmad, Haroon, Morgan Slater, Babak Aliarzadeh, et al.. (2017). Development of a preliminary essential medicines list for Canada. CMAJ Open. 5(1). E137–E143. 16 indexed citations
15.
Shah, Qaisar A., Shadi Yaghi, Randolph S. Marshall, et al.. (2017). Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 26(5). 1104–1109. 15 indexed citations
16.
Ahmad, Haroon, et al.. (2016). Ordination study of vegetation analysis around wetland area: a case study of Mangla Dam, Azad Kashmir, Pakistan.. Pakistan Journal of Botany. 48(1). 115–119. 7 indexed citations
17.
Shah, Qaisar A., Shadi Yaghi, Randolph S. Marshall, et al.. (2016). Abstract TP12: Safety of Endovascular Intervention for Acute Stroke in Patients on Anticoagulation. Stroke. 47(suppl_1).
18.
Ahmad, Haroon, et al.. (2016). The Economic Implications of Remittances on Economic Growth: The Case Study of Pakistan. International Journal of Academic Research in Business and Social Sciences. 6(7). 3 indexed citations
19.
Ahmad, Haroon, et al.. (2014). Status of Secretor and Non-Secretor with Respect to ABO Blood Group System in Young Population in Karachi-Pakistan. Journal of the Medical Sciences (Berkala Ilmu Kedokteran). 10(1). 22–25. 3 indexed citations
20.
Ahmad, Haroon, et al.. (2008). Fungal Sinusitis with Intracranial Extension in Immuno-competent Patients: Surgical Planning According to Relation to Eloquent Neurovascular Structures. Journal of Taibah University Medical Sciences. 3(1). 33–43. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan Seah Breakdown of academic impact, for papers by Matteo Monieri Breakdown of academic impact, for papers by Qiyu Tang Breakdown of academic impact, for papers by Ece Tavukçuoğlu Breakdown of academic impact, for papers by Diğdem Yöyen-Ermiş Breakdown of academic impact, for papers by Joseph Piscitelli Breakdown of academic impact, for papers by Daniel P. Feldmann Breakdown of academic impact, for papers by Ilnaz Rahimmanesh Breakdown of academic impact, for papers by Huangliang Zheng
Rankless by CCL
2026